跳至主要内容
临床试验/CTRI/2023/11/060158
CTRI/2023/11/060158尚未招募2 期

Efficacy of Histaminum hydrochoricum 30 versus IndividualisedHomoeopathic medicine in reducing symptoms of Allergic Rhinitis :A Double Blind Randamised Controlled Trial. - NI

Surya T P0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Clinically diagnosed cases of allergic rhinitis
  • 2. Both sexes of age 18-60 years
  • 3. Patients with serum IgE level above 150 IU/ml or
  • Absolute Eosinophil Count level above 440
  • cells/microlitre.

排除标准

  • 1. Patients with severe systemic illnesses like Hypertension, Diabetes Mellitus.
  • 2. Patients complicated with sinusitis,otitis media
  • 3. Patients on other medication for allergic rhinitis
  • 4. Patients with bronchial asthma
  • 5. Pregnant ladies and lactating mothers

研究者

发起方
Surya T P

相似试验